EMED Statistics
Total Valuation
EMED has a market cap or net worth of 746,459.
| Market Cap | 746,459 |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Tuesday, June 2, 2026.
| Earnings Date | Jun 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EMED has 3.73 billion shares outstanding.
| Current Share Class | 3.73B |
| Shares Outstanding | 3.73B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -64.96% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.81 |
| PB Ratio | -0.19 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.07
| Current Ratio | 0.07 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.38 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -88.83% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 26.69% |
| Weighted Average Cost of Capital (WACC) | 10.80% |
| Revenue Per Employee | 153,668 |
| Profits Per Employee | -280,300 |
| Employee Count | 6 |
| Asset Turnover | 1.30 |
| Inventory Turnover | 2.95 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks. The beta is 1.12, so EMED's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -50.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 51.89 |
| Average Volume (20 Days) | 15,416,622 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, EMED had revenue of 922,010 and -1.68 million in losses. Loss per share was -0.00.
| Revenue | 922,010 |
| Gross Profit | 692,231 |
| Operating Income | -1.01M |
| Pretax Income | -1.68M |
| Net Income | -1.68M |
| EBITDA | -1.01M |
| EBIT | -1.01M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 34,809 in cash and 1.66 million in debt, with a net cash position of -1.63 million or -0.00 per share.
| Cash & Cash Equivalents | 34,809 |
| Total Debt | 1.66M |
| Net Cash | -1.63M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -4.00M |
| Book Value Per Share | -0.01 |
| Working Capital | -4.05M |
Cash Flow
| Operating Cash Flow | -131,211 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 3,418 |
| Net Borrowing | 27,368 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.08%, with operating and profit margins of -109.62% and -182.03%.
| Gross Margin | 75.08% |
| Operating Margin | -109.62% |
| Pretax Margin | -182.03% |
| Profit Margin | -182.03% |
| EBITDA Margin | -109.25% |
| EBIT Margin | -109.62% |
| FCF Margin | n/a |
Dividends & Yields
EMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -78.66% |
| Shareholder Yield | -78.66% |
| Earnings Yield | -225.30% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EMED has an Altman Z-Score of -83.62 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -83.62 |
| Piotroski F-Score | 2 |